To evaluate the efficacy of 10 mg and 25 mg ACT-541468 on objective sleep parameters in subjects with insomnia disorder.
Multi-center, double-blind, randomized, placebo-controlled, parallel-group, polysomnography study to assess the efficacy and safety of ACT-541468 in adult and elderly subjects with insomnia disorder. For more information, please visit clinicaltrials.gov.
To learn more about this study, or to see if you qualify contact Lori Rodriquez at 913-827-4261 or email@example.com.
Idorsia Pharmaceuticals Ltd.